Aleafia Health Inc ALEAF

Healthcare Cannabis

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.

GREY:ALEAF - Post by User

Aleafia Health Inc > Bought 20k more shares

<< Previous

Bullboard Posts

Next >>

Comment by phiIip1on May 04, 2021 3:32pm

130 Views

Post# 33125159

RE:RE:Bought 20k more shares

phiIip1 wrote:

sthinei wrote: Not a shock after a parabolic rise. Also aleaf has pretty much run with sector and somd of these names not worth it. Ah being thrown out with bathwater. Example SNDL (Sundial) has market cap of 700 million, major dilution, 60 million in revs expected this year so yrading above 10x revs. Even if AH has avg price per gram of $2.50 which is low ball you are likely looking at least $150 million in revs in fy 2021. There is no pot stock trading at 3x revs but if we assume even that low multiple we can assume a price of at least 1.50. In addition to that AH may actually be profitable in Q1. Aleaf need to do a reverse split get on nasdaq and get some analyst coverage. Reverse splits seen as weakness when attempting to maintain status on those markets not when initially coming to market.